| P1.01 | Use of tele-Rehabilitation through heart transplant journey: case study of a pediatric patient with a ventricular assist device Robin Deliva, Canada |
| P1.02 | Home milrinone therapy for pediatric end-stage heart failure: The SickKids experience Kristen George, Canada |
| P1.03 | Establishing a comprehensive physical therapy evaluation for pediatric patients undergoing evaluation for lung transplant Jenna Gondelman, United States |
| P1.04 | Creation and Staff Acceptability of Standardized Caregiver/Patient-Team Agreements Gillian S Mayersohn, United States |
| P1.05 | Understanding the long-term relationship of the parental live liver donor and the adolescent young adult dyad Annette Nasr, United States |
| P1.06 | Survey of Enteral Tube Feeding Food Safety Education Practices Across Pediatric Solid-Organ Transplant Programs Rachel Damiani, United States |
| P4.01 | Clinical course of BK polyoma virus (BKPyV) infection and BKPyV-associated nephropathy in young kidney transplant recipients Manu Chhabra, Singapore |
| P4.02 | Bacillary Angiomatosis in Renal Transplant Recipient. A case Report. Carlos J Cobeñas, Argentina |
| P4.03 | Renal survival in pediatric renal transplant recipients after posttransplant lymphoproliferative disease Paula A Coccia, Argentina |
| P4.06 | The diagnosis and treatment of posttransplant lymphoproliferative disorder in pediatric liver transplant recipients Jing-Yi Liu, People's Republic of China |
| P4.08 | Non-CMV Viral Infection among Immunocompromised Patients with Acute Hypoxemic Respiratory Failure: The Utility of Non-Invasive and Invasive Diagnostic Methods Amrita Dosanjh, United States |
| P4.09 | Positive culture infections in pediatric post-liver transplantation: A ten-year experience Bogota- Colombia Maria Prieto, Colombia |
| P4.10 | Prevalence and outcomes of COVID-19 disease in pediatric kidney transplant patients in a single, US academic children’s hospital Jonathan Savant, United States |
| P4.11 | Chickenpox and rotavirus infections in children after pediatric liver transplantation: Impact in the post-transplantation course Joao Seda Neto, Brazil |
| P4.12 | Phage therapy to allow liver transplantation in a toddler infected by an extensively drug-resistant Pseudomonas aeruginosa Brieuc Van Nieuwenhuyse, Belgium |
| P4.14 | Nondestructive versus advanced post-transplant lymphoproliferative disorder in a single center pediatric kidney transplant population Ellen Wu, United States |
| P4.15 | Liver transplantation in pediatric patient with Covid 19: Sistematic review and case report Maria Prieto, Colombia |
| P4.16 | Effect of Epstein Barr Virus infection on pharmacokinetics of tacrolimus; report of a single center study Hubert van der Doef, Netherlands |
| P5.04 | Subclinical cardiac dysfunction in pediatric kidney transplant recipients: Cardiac strain measurements by two-dimensional speckle tracking echocardiography Adrienn Bárczi, Hungary |
| P5.05 | Uncovering a long-term graft survival advantage afforded by infant renal transplants-an Organ Procurement and Transplantation Network database analysis Lavjay Butani, United States |
| P5.08 | Longitudinal studies of blood anellovirus DNA prior to acute rejection or major infection events in Pediatric Kidney Transplant Recipients (PKTx). Raja Dandamudi, United States |
| P5.10 | Therapeutic management of paediatric Schimke immuno-osseous dysplasia patients with kidney transplantation: a 20 year experience of a french center Laurene Dehoux, France |
| P5.12 | Bortezomib for antibody-mediated rejection of renal transplant in youth Lauren E Galea, United States |
| P5.13 | Denys Drash and Fraiser syndrome - experiences from a National Transplant centre Ann Christin Gjerstad, Norway |
| P5.14 | Long Term Outcomes of Kidney Transplant in Pediatric Recipients Emre Karakaya, Turkey |
| P5.15 | The Reliability and Validity Study of Pediatric Transplant Rating Instrument in Turkish Renal Transplant Patients Hande Ayraler Taner, Turkey |
| P5.16 | Donation after circulatory death in pediatric kidney transplantation, same graft survival as donation after brain death Maria Herero Goni, Spain |
| P5.17 | Ten Years Paediatric Kidney Transplant Review in Hong Kong Tsz Wai Ho, Hong Kong |
| P5.18 | Pediatric transplant surgeons’ perspectives on palliative care for children with chronic kidney disease: a national cross-sectional survey Taylor R House, United States |
| P5.19 | The impact of donor-recipient size mismatch on the outcomes of paediatric renal transplantation Ioannis D. Kostakis, United Kingdom |
| P5.20 | A case of bullous pemphigoid in an immunosuppressed renal transplant child- a paradoxical phenomenon? Grainne M Walsh, United Kingdom |
| P5.22 | The effect of donor age on pediatric kidney graft survival Loes Oomen, Netherlands |
| P5.23 | Posttransplant lymphoproliferative disorders: A single center experience Natalia Yanet Panero Schipper, Argentina |
| P5.27 | Treatment of Post-Transplant Recurrent FSGS in Children Using Plasmapheresis and Augmentation of Immunosuppression Jaime Restrepo, Colombia |
| P5.28 | Pediatric kidney transplantation: Experience of 25 years in a high complexity Hospital of Colombia Jaime Restrepo, Colombia |
| P5.29 | Characterization of adolescents with kidney transplantation or pre-transplant protocol previous to set up a transition program (STARx) in Cali, Colombia Jaime Restrepo, Colombia |
| P5.30 | Effects of fecal microbiota transplantation for recurrent clostridium difficile infection in children with renal replacement therapy Noël Knops, Belgium |
| P5.32 | LDL apheresis as part of successful rescue therapy for treatment-refractory recurrent FSGS Michael JG Somers, United States |
| P5.33 | Basal metabolic rate before and after kidney transplantation Yusuke Takahashi, Japan |
| P6.01 | Spontaneous Portosystemic Shunt Ligation During Pediatric Liver Transplantation Megan A Adams, United States |
| P6.03 | Sequential liver and hematopoietic stem cell transplantation in a child with erythropoietic protoporphyria: a case report Denise Aldrian, Austria |
| P6.04 | Long-term nutritional status in Pediatric Small Bowel Transplantation Ane M Andres, Spain |
| P6.06 | Correlation of activated partial thromboplastin time versus anti-Xa levels for unfractionated heparin monitoring in postoperative pediatric liver transplant patients Rebecca Brocks, Canada |
| P6.09 | Long term outcomes of liver transplantation for metabolic defects. A single center report Srinath Chinnakotla, United States |
| P6.10 | Multi-faceted peri-transplant strategy for biliary atresia candidates for liver transplantation; effect on access to transplantation and outcome Serena Abbate, Italy |
| P6.11 | Splenic artery aneurysms in children with cirrhosis and portal hypertension: risk factors and treatment strategies Marcos E Pozo, United States |
| P6.12 | Carfilzomib desensitization for antibody-mediated rejection in a pediatric liver transplant recipient Danielle Romero, United States |
| P6.13 | Indications for liver or multivisceral transplantation: a diffuse borderline Javier Serradilla, Spain |
| P6.14 | Stumbling in the dark: A late presentation of vitamin A deficiency in a pediatric multivisceral transplant patient Leanna Shea, United States |
| P6.15 | Incidence and management of portal vein complications after pediatric liver transplantation Roberto Tambucci, Belgium |
| P6.16 | Favorable Long-term Renal Outcome following Pediatric Liver Transplantation Su young Hong, Korea |
| P6.17 | Postoperative bacteremia is associated with early vascular complications in pediatric liver transplant recipients with biliary atresia Kyong Ihn, Korea |
| P6.18 | A longitudinal study on the long term renal outcome of children after liver transplantation in relation to tacrolimus exposure and their pharmacogenetic background Noël Knops, Belgium |
| P6.19 | Whole Liver Transplantation with Significant Donor-Recipient Size Mismatch: Role of Objective Assessment Chandrashekhar A Kubal, United States |
| P6.21 | Effectiveness of antibody-removal therapy in pediatric intestinal transplant recipients Ane M Andres, Spain |
| P6.23 | Assessment of Long-term Outcomes of Pediatric Liver Transplant Recipients Emre Karakaya, Turkey |
| P6.24 | CNI free Immunosuppression with Everolimus in children post liver transplantation: A retrospective pilot study. Eberhard Lurz, Germany |
| P6.25 | Liver transplantation for hepatic epithelioid hemangioendothelioma with lung metastases in a pediatric patient Ivone E Malla, Argentina |
| P6.26 | Impact of COVID-19 on liver transplant recipients: the experience of a pediatric liver transplantation unit Rita Marchante Pita, Portugal |
| P6.29 | Characteristics of de novo autoimmune hepatitis in pediatric liver-small bowel transplant recipients Hanh D. Vo, United States |
| P6.30 | Timing and Effect of Liver Transplantation in Five Patients with Primary Hyperoxaluria Type 1: A Retrospective Review? Xin-yue Wang, People's Republic of China |
| P6.31 | Plasma galectin-3 is predictive of post-transplant infection in pediatric liver transplant recipients Dor Yoeli, United States |
| P6.32 | Five cases of familial hypercholesterolemia treated by liver transplantation Haosu Zhan, People's Republic of China |
| P6.33 | Liver transplantation for urea cycle disorders Hao Huang, People's Republic of China |
| P10.01 | Cardiomyopathy due to propionic acidemia: is there any space for liver transplant? Elisa Bellettini, Italy |
| P10.02 | Effect of rituximab treatment on plasma EBV miRNAs: Longitudinal profiling in three paediatric kidney transplant recipients. Jaythoon Hassan, Ireland |
| P7.02 | Implementation of a tight control of blood pressure improve postoperative outcomes in children receiving liver transplantation Mihaela A Damian, United States |
| P7.04 | Healthcare transition preparation in adolescents with kidney transplantation or pre transplant in Cali Colombia Jaime Restrepo, Colombia |
| P7.06 | Transition Program for Young Adults with Solid Organ Transplants - A Single Center Protocol Hannah Y Lee, United States |
| P7.07 | A comprehensive checklist for children with advanced kidney disease to coordinate care after hospital discharge Michael JG Somers, United States |
| P8.02 | Comparison of primary liver transplantation and transplantation after Kasai portoenterostomy for pediatric liver transplant outcomes for biliary atresia John P Leshock, United States |
| P8.04 | Early versus late ureteral stent removal in pediatric kidney transplant recipients Lynn K Maestretti, United States |
| P8.05 | Neurologic complications in en bloc pediatric heart-liver transplants Jenny Pan, United States |
| P8.06 | Technical Aspects and Outcomes in Reconstruction of Anomalous Hepatic Vein Anatomy of Left Lateral Segment Liver Grafts in Pediatric Living Donor Liver Transplantation Joao Seda Neto, Brazil |
| P9.02 | Post-COVID myocardial damage requiring mechanical circulatory support and heart transplantation (case report) Csaba Vilmányi, Hungary |
| P9.03 | Use of a dyspnea assessment tool and non-pharmacological methods to decrease opioid use in patients waiting for lung transplant Dawn Freiberger, United States |
| P11.01 | Worldwide disparities in pediatric liver transplantation cost. Can we decrease what we use to make an impact? Angel Flores Huidobro Martinez, Mexico |
| P11.03 | The Environmental Impact of a Solid Organ Transplant Program: Vehicle Emissions, Patient Travel and Time James E. Potts, Canada |